Weight Loss Consultation
With MyPharmacyServices, you get more than just medication. Our experienced clinicians provide a supportive, personalised consultation and, where appropriate, prescription treatment such as Wegovy or Mounjaro—plus ongoing guidance to help you reach your goals safely and effectively.
Typically for adults with BMI ≥30, or ≥27 with weight‑related risks—we’ll confirm in your consult.
Most people who meet the criteria can start safely after a short consult.
Consultation fee: £30. Includes assessment, advice, and—if suitable—an e‑prescription to your chosen UK pharmacy.
Medication cost: set by the pharmacy (we do not dispense).
What to prepare
Photo ID · Current weight & height · Medicines/allergies · Medical history (e.g., diabetes, thyroid) · Preferred UK pharmacy (name/postcode)
Weight Loss Treatment Overview
Losing weight isn’t just about appearance—it can improve health and energy and lower the risk of long‑term conditions like type 2 diabetes, high blood pressure and heart disease. We offer pharmacist‑led consultations with tailored advice. If suitable, you may be prescribed a weekly weight‑loss injection such as Wegovy (semaglutide) or Mounjaro (tirzepatide).
Wegovy (semaglutide)
How it works: Mimics a natural hormone to help reduce appetite.
Dosing: Once‑weekly injection, dose increased gradually.
Effectiveness: Many patients achieve meaningful weight loss (results vary).
Common side effects: Nausea, headache, constipation (often settle).
How to use Wegovy https://www.wegovy.co.uk/content/dam/nnsites/wegovy-co-uk/en/support-materials/pdfs/how-to-use-wegovy-infographic-may-2025.pdf
Wegovy Patient Brochure https://www.wegovy.co.uk/content/dam/nnsites/wegovy-co-uk/en/pdfs/wegovy-cv-gb-digital-patient-brochure-jan-2025.pdf
Official Wegovy UK site https://www.wegovy.co.uk/home.html
Mounjaro (tirzepatide)
How it works: Dual‑action approach supporting appetite control and glucose regulation.
Dosing: Once‑weekly injection with gradual titration.
Effectiveness: Some patients achieve greater weight loss than with single‑action treatments (results vary).
Common side effects: Nausea, diarrhoea, reduced appetite.
Mounjaro Patient Booklet (Eli Lilly UK): https://uk.lilly.com/metabolic/assets/pdf/mounjaro-patient-booklet.pdf
Wegovy — How to use the Wegovy pen: https://www.wegovy.com/taking-wegovy/how-to-use-the-wegovy-pen.html
Mounjaro — How to use the pen: https://mounjaro.lilly.com/how-to-use-mounjaro
Mounjaro — KwikPen video (official Lilly Canada): https://www.lilly.com/en-CA/resources/faq/mounjaro-kwikpen/use-kwikpen
(Device versions may vary by market—always follow the UK Instructions for Use supplied with your pen.)
Who this is for
Adults seeking evidence‑based support for weight management.
Typically BMI ≥30, or ≥27 with weight‑related conditions (your clinician will confirm).
Who it might not suit right now
Pregnancy or breastfeeding.
Certain thyroid conditions (e.g., MEN2/MTC).
Past pancreatitis or severe stomach/gut disease.
Currently using another GLP‑1 medicine.
Type 1 diabetes.
Recent bariatric surgery or an active eating disorder.
Complex mental health needs — we’ll discuss safer alternatives if needed.
Monitoring & reviews
Monthly check‑ins to support progress and comfort. If progress is limited after several months, we’ll review whether to continue (many programmes use ~5% at 6 months as a guide).
Prescriptions & supply
We usually start with a 1‑month prescription and review monthly. Prescriptions are sent electronically to your chosen UK pharmacy.
Wegovy vs. Mounjaro: At a Glance
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| Frequency | Weekly | Weekly |
| Average Weight Loss | Up to 15% | Over 20% |
| NHS Availability | Limited | Limited |
| Private Availability | Yes (with consultation) | Yes (with consultation) |
| Eligibility | ≥30 BMI or ≥27 with conditions | ≥30 BMI or ≥27 with conditions |
How it works
Book online: choose a suitable time.
Remote consultation: we review your health, goals and suitability.
Prescription (if appropriate): e‑prescription sent to your preferred UK pharmacy.
Follow‑up: ongoing guidance on dosing, side‑effects and results.
Questions before you book? Email us at info@mypharmacyservices.co.uk or call +44 3030 401 082.